| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.002 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |